Researchers identify genes that may improve success of fecal microbe transplants

Fecal microbe transplants from healthy donors can treat patients with recurrent Clostridium difficile infections. However, after tens of thousands transplants, little was known about which donor strains provide long-term engraftment, and which engraft early after the transplant.

Paytient Appoints Joe Gabler as Chief Growth Officer

Joe Gabler, Chief Growth Officer at Paytient What You Should Know: – Paytient, the leading innovator in health plan affordability solutions, today announced the appointment

May 8, 2024

Risk adjusted net present value: What is the current valuation of Vigil Neuroscience’s Iluzanebart?

Iluzanebart is a monoclonal antibody commercialized by Vigil Neuroscience, with a leading Phase III program in Neurodegenerative Diseases.

December 14, 2024

Crossject secures funding from French Government for needle-free platform – Pharmaceutical Technology

Crossject’s single-use prefilled device propels medicine through the skin in less than one tenth of a second. Credit: Crossject. French company Crossject has secured €6.9m

July 14, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.